Progress on Chitosan Nanoparticles as Drug Delivery Carriers

Article Preview

Abstract:

To review the progress on chitosan nanoparticles as drug delivery carriers, the application of chitosan nanoparticles in the fields of organ targeting, DNA transfection, and non-injection administration are summarized according to recent references. The results showed that chitosan nanoparticles as a new drug carrier have important value of research and extensively development prospect.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

53-56

Citation:

Online since:

April 2013

Authors:

Export:

Price:

[1] Huang M, Ma Z, Khor E. Uptake of FITC-chitosan nanoparticles by A 549 cells [J]. Pharm res. 2002, 19(10): 1488-1494.

Google Scholar

[2] Huang M, Ma Z, Khor E, Lim LY, et al. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation[J]. Pharm res. 2004, 21(2): 344-353.

DOI: 10.1023/b:pham.0000016249.52831.a5

Google Scholar

[3] Ma Z, Lim LY, et al. Uptake of chitosan and associated insulin in caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles : effects of molecular weight and degree of deacetylation[J]. Pharm res. 2003, 20(11): 1812-1819.

DOI: 10.1023/b:pham.0000003379.76417.3e

Google Scholar

[4] Janes KA, Fresneau MP, Marazuela A, et al. chitosan nanoparticles as delivery systems for doxorubicin[J]. J Control Release. 2001, 73(2-3):255-267.

DOI: 10.1016/s0168-3659(01)00294-2

Google Scholar

[5] Mitra S, Gaur U, Chosh PC, et al. Tumour targeted delivery of eucapsulated dextran- doxorubicin conjugate using chitosan nanoparticles as carrier[J]. J Control Release 2001, 74(1-3):317-323.

DOI: 10.1016/s0168-3659(01)00342-x

Google Scholar

[6] Mao HQ, Roy K, Troung-Le VL, et al. chitosan DNA nanoparticles as gene delivery carriers: Synthesis characterization and transfection efficiency [J]. J Control Release 2001, 70 (3):399-421.

DOI: 10.1016/s0168-3659(00)00361-8

Google Scholar

[7] Park IK, Jiang HL, Cook SE, et al. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone)(pvp) as hepatocyle-targeting DNA carrier in vitro transfection, MG63 and HEK293 transfection [J]. Arch Pharm res. 2004, 27(12): 1284-1289.

DOI: 10.1007/bf02975895

Google Scholar

[8] Kim TH, Kim SL, Akaike T, et al. Synergistic effect of poly(ethylenimine)on the transfection efficiency of galactosylated chitosan / DNA complexes [J]. J Control Release 2005, 105(3): 354-366.

DOI: 10.1016/j.jconrel.2005.03.024

Google Scholar

[9] Vila A, Sanchez A, Janes K, et al. low molecular weight chitosan nanoparticles as new carriaers for nasal vaccine delivery in mice [J]. Eur J Pharm Biopharm. 2004, 57(1): 123-131.

DOI: 10.1016/j.ejpb.2003.09.006

Google Scholar

[10] Decampos AM, Sancheiz A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A[J]. Int J Pharm, 2001, 224(1-2):159-168.

DOI: 10.1016/s0378-5173(01)00760-8

Google Scholar

[11] Decampos AM, Diebold Y, Carvalho EL, et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity[J]. Pharm Res. 2004, 21 (5): 803-810.

DOI: 10.1023/b:pham.0000026432.75781.cb

Google Scholar